These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9408446)

  • 1. The clinical significance of adynamic bone disease in uremia.
    Fournier A; Said S; Ghazali A; Sechet A; Ezaitouni F; Marie A; Westeel PF; Morinière P; Boudailliez B
    Adv Nephrol Necker Hosp; 1997; 27():131-66. PubMed ID: 9408446
    [No Abstract]   [Full Text] [Related]  

  • 2. Skeletal resistance to parathyroid hormone as a background abnormality in uremia.
    Fukagawa M; Iwasaki Y; Kazama JJ
    Nephrology (Carlton); 2003 Oct; 8 Suppl():S50-2. PubMed ID: 15012692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Parathyroid hormone (PTH)].
    Sato K
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():288-91. PubMed ID: 16149511
    [No Abstract]   [Full Text] [Related]  

  • 5. [Adynamic bone disease in kidney failure. Role of aluminum].
    Cohen-Solal ME; Sebert JL; Morinière P; Fournier A
    Rev Rhum Ed Fr; 1993 May; 60(5):361-4. PubMed ID: 8167643
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of lowering dialysate calcium concentration on serum bone turnover markers in hemodialysis patients.
    Hamano T; Oseto S; Fujii N; Ito T; Katayama M; Horio M; Imai E; Hori M
    Bone; 2005 May; 36(5):909-16. PubMed ID: 15794928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of vitamin K2 in hemodialysis patients with low serum parathyroid hormone levels.
    Nakashima A; Yorioka N; Doi S; Masaki T; Ito T; Harada S
    Bone; 2004 Mar; 34(3):579-83. PubMed ID: 15003806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hemodialysis and renal failure on serum biochemical markers of bone turnover.
    Alvarez L; Torregrosa JV; Peris P; Monegal A; Bedini JL; Martinez De Osaba MJ; Filella X; Martin G; Ricos C; Oppenheimer F; Ballesta AM
    J Bone Miner Metab; 2004; 22(3):254-9. PubMed ID: 15108068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of uremia.
    Hamburger RJ
    Am Fam Physician; 1977 Sep; 16(3):125-32. PubMed ID: 331923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Target range of PTH in uremia].
    Tahara H; Tabata T
    Clin Calcium; 2004 Jan; 14(1):39-44. PubMed ID: 15576952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum level of intact parathyroid hormone and other markers of bone metabolism in dialyzed patients.
    Grzegorzewska AE; Młot-Michalska M
    Adv Perit Dial; 2007; 23():162-5. PubMed ID: 17886625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Low PTH level and adynamic bone disease in dialysis patients].
    Shiizaki K; Sumikado S; Akizawa T
    Clin Calcium; 2004 Jan; 14(1):16-20. PubMed ID: 15576948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients.
    Benyahia M; Shahapuni I; Ghazali A; Massy Z; Fournier A
    Nephrol Dial Transplant; 2004 Aug; 19(8):2153; author reply 2153-4. PubMed ID: 15252181
    [No Abstract]   [Full Text] [Related]  

  • 14. Renal osteodystrophy; some therapeutic consideration relative to long-term dialysis and transplantation.
    Rubini ME; Cobun JW; Massry SG; Shinaberger JH
    Arch Intern Med; 1969 Dec; 124(6):663-9. PubMed ID: 4901062
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypercalcemia, hypertension and acute renal insufficiency in an immobilized adolescent.
    Karpati RM; Mak RH; Lemley KV
    Child Nephrol Urol; 1991; 11(4):215-9. PubMed ID: 1777905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcoidosis-related hypercalcemia in 3 chronic hemodialysis patients.
    Huart A; Kamar N; Lanau JM; Dahmani A; Durand D; Rostaing L
    Clin Nephrol; 2006 Jun; 65(6):449-52. PubMed ID: 16792143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Magnesium balance in terminal chronic uremia].
    Corrado F; Zucchelli P; Fusaroli M; Sasdelli M; Maver A
    Minerva Nefrol; 1969; 16(6):403-6. PubMed ID: 5403802
    [No Abstract]   [Full Text] [Related]  

  • 18. Some medical problems of chronic hemodialysis.
    Gral T; Sokol A; Rubini ME
    Isr J Med Sci; 1967; 3(1):14-27. PubMed ID: 6067675
    [No Abstract]   [Full Text] [Related]  

  • 19. [The K/DOQI guidelines on diagnosis and treatment of aluminum bone disease in hemodialysis patients].
    Nakazawa R
    Clin Calcium; 2004 May; 14(5):738-43. PubMed ID: 15577035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biological markers of bone turnover in renal failure].
    Ureña P
    Ann Biol Clin (Paris); 2001; 59(3):313-6. PubMed ID: 11397681
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.